About Ayati Pharma
Ayati Pharma is a Healthcare company based in Mumbai (India). It offers pharmaceutical services and affordable medicines to companies worldwide. It operates on a B2B model. Its Indian entity Ayati Pharma Private Limited reported revenue of ₹1.70 Cr. Ayati Pharma offers products and services including Anti Hypertensives, Anti Diabetics, Proton Pump Inhibitor, and Supportive Therapy. Its focus areas include Pharmaceuticals, Drug Manufacturing, Prescription Drugs and Supportive Therapy.
Company details
Ayati Pharma Is A Pharmaceutical Company Based In England With Offices In India, Providing High-quality, Affordable Medicines And Services To Global Pharmaceutical Firms. It Focuses On Innovation, Ethical Standards, And Patient-friendly Solutions In Healthcare. The Company Manufactures Products Like Anti-hypertensives And Anti-diabetics, Emphasizing Performance-driven Culture And Transparency In Operations. Serving Communities By Enhancing Public Wellness Through Accessible Healthcare Solutions.
- Headquarters Mumbai, India
- SectorsHealthcare
- Email••••••••
- Website ayatipharma.com
- Legal Name Ayati Pharma Private Limited
- Date of Incorporation 28 Sep, 2017
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹1.70 Cr
FY 2024 · +14% YoY
- Net Profit₹7.3 Lakh
FY 2024 · 4% margin
- EBITDA₹10.1 Lakh
FY 2024 · 6% margin
Associated legal entities of Ayati Pharma
Ayati Pharma operates through Ayati Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Ayati Pharma Private Limited CIN U74999MH2017PTC300240 | Active | 28 Sep 2017 | Mumbai, Maharashtra | ₹1.7 Cr | 3 | View details |
Products & Services of Ayati Pharma
Ayati Pharma offers a comprehensive portfolio of products and services, including Anti Hypertensives, Anti Diabetics, Proton Pump Inhibitor, and Supportive Therapy.
Treatments for high blood pressure and related conditions.
Medications for managing diabetes effectively.
Drugs to reduce stomach acid production.
Products aiding general health and recovery processes.
Board of directors of Ayati Pharma Private Limited (Ayati Pharma)
Ayati Pharma Private Limited is the primary company behind Ayati Pharma. The board of Ayati Pharma Private Limited currently have 3 directors; the longest-serving is Akula Krishnarjuna Rao, appointed in 2017. 5 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Akula Krishnarjuna Rao DIN 07951840 | Director | 28 Sep 2017 | 9 yrs | Ayati Pharma Private Limited |
| Shankar Rajapuram DIN 07949504 | Director | 28 Sep 2017 | 9 yrs | Ayati Pharma Private Limited |
| Krishnam Siva Vara Prasad DIN 07949508 | Director | 28 Sep 2017 | 9 yrs | Ayati Pharma Private Limited |
Financials of Ayati Pharma
Figures of Ayati Pharma Private Limited, the primary company behind Ayati Pharma, for FY 2024. Revenue was ₹1.70 Cr (+14% year on year). Net profit was ₹7.3 Lakh (4% margin). EBITDA was ₹10.1 Lakh (6% margin). Revenue has grown at a compounded annual rate of +22% over three years and +22% over five years.
- ₹1.70 CrRevenue · FY 2024 · +14% YoY
- ₹7.3 LakhNet profit · 4% margin
- ₹10.1 LakhEBITDA · 6% margin
- ₹6 LakhPaid-up capital
- +22%Revenue CAGR, 3 years
- +22%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Ayati Pharma Private Limited are on its company page.
Detailed financial statements for Ayati Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Ayati Pharma
Ayati Pharma is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
The primary company behind Ayati Pharma, Ayati Pharma Private Limited, reported revenue of ₹1.70 Cr for FY 2024, up 14% year on year.
Ayati Pharma Is A Pharmaceutical Company Based In England With Offices In India, Providing High-quality, Affordable Medicines And Services To Global Pharmaceutical Firms. It Focuses On Innovation, Ethical Standards, And Patient-friendly Solutions In Healthcare. The Company Manufactures Products Like Anti-hypertensives And Anti-diabetics, Emphasizing Performance-driven Culture And Transparency In Operations. Serving Communities By Enhancing Public Wellness Through Accessible Healthcare Solutions.
Ayati Pharma offers Anti Hypertensives, Anti Diabetics, Proton Pump Inhibitor, and Supportive Therapy.
Ayati Pharma operates through Ayati Pharma Private Limited.
The legal entities of Ayati Pharma currently have 3 directors, including Akula Krishnarjuna Rao, Shankar Rajapuram, Krishnam Siva Vara Prasad.